Piper Sandler upgraded the previous rating for Shoals Technologies Group Inc (NASDAQ:SHLS) from Neutral to Overweight. In the second quarter, Shoals Technologies Gr showed an EPS of $0.14, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.37 and a 52-week-low of $15.06. Shoals Technologies Gr closed at $15.10 at the end of the last trading period.

According to Piper Sandler, the prior rating for Kemper Corp (NYSE:KMPR) was changed from Neutral to Overweight. In the second quarter, Kemper showed an EPS of $0.26, compared to $0.62 from the year-ago quarter. The current stock performance of Kemper shows a 52-week-high of $68.15 and a 52-week-low of $38.32. Moreover, at the end of the last trading period, the closing price was at $41.47.

Keefe, Bruyette & Woods upgraded the previous rating for Cambridge Bancorp (NASDAQ:CATC) from Market Perform to Outperform. In the second quarter, Cambridge showed an EPS of $1.23, compared to $1.90 from the year-ago quarter. The current stock performance of Cambridge shows a 52-week-high of $92.58 and a 52-week-low of $44.62. Moreover, at the end of the last trading period, the closing price was at $59.33.

According to UBS, the prior rating for Vale SA (NYSE:VALE) was changed from Sell to Neutral. In the second quarter, Vale showed an EPS of $0.20, compared to $1.32 from the year-ago quarter. The current stock performance of Vale shows a 52-week-high of $19.31 and a 52-week-low of $12.22. Moreover, at the end of the last trading period, the closing price was at $12.78.

According to Craig-Hallum, the prior rating for CalAmp Corp (NASDAQ:CAMP) was changed from Buy to Hold. For the second quarter, CalAmp had an EPS of $0.11, compared to year-ago quarter EPS of $0.02. The current stock performance of CalAmp shows a 52-week-high of $5.36 and a 52-week-low of $0.29. Moreover, at the end of the last trading period, the closing price was at $0.45.

JP Morgan downgraded the previous rating for G1 Therapeutics Inc (NASDAQ:GTHX) from Neutral to Underweight. For the second quarter, G1 Therapeutics had an EPS of $0.14, compared to year-ago quarter EPS of $0.92. At the moment, the stock has a 52-week-high of $13.85 and a 52-week-low of $1.14. G1 Therapeutics closed at $1.27 at the end of the last trading period.

According to Oppenheimer, the prior rating for O'Reilly Automotive Inc (NASDAQ:ORLY) was changed from Outperform to Perform. For the second quarter, O'Reilly Automotive had an EPS of $10.22, compared to year-ago quarter EPS of $8.78. The stock has a 52-week-high of $975.72 and a 52-week-low of $705.74. At the end of the last trading period, O'Reilly Automotive closed at $900.80.

Oppenheimer downgraded the previous rating for AutoZone Inc (NYSE:AZO) from Outperform to Perform. In the fourth quarter, AutoZone showed an EPS of $46.46, compared to $40.51 from the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of $2750.00 and a 52-week-low of $2165.93. Moreover, at the end of the last trading period, the closing price was at $2521.68.

For Univest Financial Corp (NASDAQ:UVSP), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. Univest Financial earned $0.61 in the second quarter, compared to $0.45 in the year-ago quarter. At the moment, the stock has a 52-week-high of $29.06 and a 52-week-low of $16.11. Univest Financial closed at $17.44 at the end of the last trading period.

For PTC Therapeutics Inc (NASDAQ:PTCT), Truist Securities downgraded the previous rating of Buy to Hold. PTC Therapeutics earned $1.48 in the second quarter, compared to $2.13 in the year-ago quarter. The current stock performance of PTC Therapeutics shows a 52-week-high of $59.84 and a 52-week-low of $20.17. Moreover, at the end of the last trading period, the closing price was at $22.20.

According to Raymond James, the prior rating for POINT Biopharma Global Inc (NASDAQ:PNT) was changed from Outperform to Market Perform. For the second quarter, POINT Biopharma Global had an EPS of $0.24, compared to year-ago quarter EPS of $0.27. At the moment, the stock has a 52-week-high of $12.41 and a 52-week-low of $5.59. POINT Biopharma Global closed at $12.40 at the end of the last trading period.

With a Buy rating, Craig-Hallum initiated coverage on Stagwell Inc (NASDAQ:STGW). The price target seems to have been set at $8.00 for Stagwell. Stagwell earned $0.16 in the second quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Stagwell shows a 52-week-high of $9.23 and a 52-week-low of $4.09. Moreover, at the end of the last trading period, the closing price was at $4.11.

With a Buy rating, Ladenburg Thalmann initiated coverage on NiSource Inc (NYSE:NI). The price target seems to have been set at $25.00 for NiSource. In the second quarter, NiSource showed an EPS of $0.11, compared to $0.12 from the year-ago quarter. The stock has a 52-week-high of $28.95 and a 52-week-low of $22.86. At the end of the last trading period, NiSource closed at $23.83.

With a Neutral rating, Citigroup initiated coverage on NuStar Energy LP (NYSE:NS). The price target seems to have been set at $17.00 for NuStar Energy. In the second quarter, NuStar Energy showed an EPS of $0.09, compared to $0.19 from the year-ago quarter. The current stock performance of NuStar Energy shows a 52-week-high of $18.41 and a 52-week-low of $13.79. Moreover, at the end of the last trading period, the closing price was at $16.78.

Seaport Global initiated coverage on Warner Bros. Discovery Inc (NASDAQ:WBD) with a Buy rating. The price target for Warner Bros. Discovery is set to $19.00. In the second quarter, Warner Bros. Discovery showed an EPS of $0.51, compared to $1.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.34 and a 52-week-low of $8.82. Warner Bros. Discovery closed at $10.09 at the end of the last trading period.

With a Buy rating, Seaport Global initiated coverage on Paramount Global (NASDAQ:PARA). The price target seems to have been set at $17.00 for Paramount Global. In the second quarter, Paramount Global showed an EPS of $0.10, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $25.93 and a 52-week-low of $11.48. At the end of the last trading period, Paramount Global closed at $11.67.

Seaport Global initiated coverage on Netflix Inc (NASDAQ:NFLX) with a Buy rating. The price target for Netflix is set to $482.00. In the second quarter, Netflix showed an EPS of $3.29, compared to $3.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $485.00 and a 52-week-low of $211.81. Netflix closed at $372.59 at the end of the last trading period.

With a Buy rating, Seaport Global initiated coverage on Comcast Corp (NASDAQ:CMCSA). The price target seems to have been set at $53.00 for Comcast. In the second quarter, Comcast showed an EPS of $1.13, compared to $1.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $47.45 and a 52-week-low of $28.39. Comcast closed at $43.02 at the end of the last trading period.

With a Buy rating, Seaport Global initiated coverage on AMC Networks Inc (NASDAQ:AMCX). The price target seems to have been set at $16.00 for AMC Networks. AMC Networks earned $2.02 in the second quarter, compared to $2.06 in the year-ago quarter. The current stock performance of AMC Networks shows a 52-week-high of $27.46 and a 52-week-low of $9.96. Moreover, at the end of the last trading period, the closing price was at $11.17.

With a Buy rating, Jefferies initiated coverage on Laureate Education Inc (NASDAQ:LAUR). The price target seems to have been set at $20.00 for Laureate Education. For the second quarter, Laureate Education had an EPS of $0.35, compared to year-ago quarter EPS of $0.25. The current stock performance of Laureate Education shows a 52-week-high of $14.80 and a 52-week-low of $9.24. Moreover, at the end of the last trading period, the closing price was at $13.55.

With a Buy rating, UBS initiated coverage on MarketAxess Holdings Inc (NASDAQ:MKTX). The price target seems to have been set at $285.00 for MarketAxess Holdings. For the second quarter, MarketAxess Holdings had an EPS of $1.59, compared to year-ago quarter EPS of $1.78. The stock has a 52-week-high of $399.78 and a 52-week-low of $200.01. At the end of the last trading period, MarketAxess Holdings closed at $225.61.

With a Equal-Weight rating, Barclays initiated coverage on UniFirst Corp (NYSE:UNF). The price target seems to have been set at $160.00 for UniFirst. In the third quarter, UniFirst showed an EPS of $1.66, compared to $1.77 from the year-ago quarter. At the moment, the stock has a 52-week-high of $205.59 and a 52-week-low of $150.50. UniFirst closed at $159.09 at the end of the last trading period.

With a Buy rating, HSBC initiated coverage on Brookfield Asset Management Ltd (NYSE:BAM). The price target seems to have been set at $39.00 for Brookfield Asset Mgmt. For the second quarter, Brookfield Asset Mgmt had an EPS of $0.28, compared to year-ago quarter EPS of $0.34. The current stock performance of Brookfield Asset Mgmt shows a 52-week-high of $47.53 and a 52-week-low of $26.79. Moreover, at the end of the last trading period, the closing price was at $31.20.

With a Hold rating, HSBC initiated coverage on Blackstone Inc (NYSE:BX). The price target seems to have been set at $113.00 for Blackstone. Blackstone earned $0.93 in the second quarter, compared to $1.49 in the year-ago quarter. At the moment, the stock has a 52-week-high of $116.78 and a 52-week-low of $71.73. Blackstone closed at $104.19 at the end of the last trading period.

With a Buy rating, Roth MKM initiated coverage on Chemomab Therapeutics Ltd (NASDAQ:CMMB). The price target seems to have been set at $7.00 for Chemomab Therapeutics. For the second quarter, Chemomab Therapeutics had an EPS of $0.72, compared to year-ago quarter EPS of $0.54. At the moment, the stock has a 52-week-high of $5.35 and a 52-week-low of $0.80. Chemomab Therapeutics closed at $0.83 at the end of the last trading period.

With a Buy rating, JonesTrading initiated coverage on The Real Brokerage Inc (NASDAQ:REAX). The price target seems to have been set at $2.50 for Real Brokerage. In the second quarter, Real Brokerage showed an EPS of $0.02, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $1.99 and a 52-week-low of $1.00. At the end of the last trading period, Real Brokerage closed at $1.54.

With a Buy rating, Seaport Global initiated coverage on The Walt Disney Co (NYSE:DIS). The price target seems to have been set at $93.00 for Walt Disney. In the third quarter, Walt Disney showed an EPS of $1.03, compared to $1.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $118.18 and a 52-week-low of $78.73. Walt Disney closed at $80.81 at the end of the last trading period.

Bernstein initiated coverage on Charter Communications Inc (NASDAQ:CHTR) with a Market Perform rating. The price target for Charter Communications is set to $463.00. Charter Communications earned $8.05 in the second quarter, compared to $8.80 in the year-ago quarter. The current stock performance of Charter Communications shows a 52-week-high of $457.66 and a 52-week-low of $297.83. Moreover, at the end of the last trading period, the closing price was at $431.78.

With an Underperform rating, Bernstein initiated coverage on Paramount Global (NASDAQ:PARA). The price target seems to have been set at $11.00 for Paramount Global. In the second quarter, Paramount Global showed an EPS of $0.10, compared to $0.64 from the year-ago quarter. The current stock performance of Paramount Global shows a 52-week-high of $25.93 and a 52-week-low of $11.48. Moreover, at the end of the last trading period, the closing price was at $11.67.

Bernstein initiated coverage on Warner Bros. Discovery Inc (NASDAQ:WBD) with an Outperform rating. The price target for Warner Bros. Discovery is set to $13.00. For the second quarter, Warner Bros. Discovery had an EPS of $0.51, compared to year-ago quarter EPS of $1.05. The current stock performance of Warner Bros. Discovery shows a 52-week-high of $16.34 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $10.09.

With a Market Perform rating, TD Cowen initiated coverage on Fidelity National Information Services Inc (NYSE:FIS). The price target seems to have been set at $56.00 for Fidelity National Info. For the second quarter, Fidelity National Info had an EPS of $1.55, compared to year-ago quarter EPS of $1.73. The stock has a 52-week-high of $85.17 and a 52-week-low of $48.57. At the end of the last trading period, Fidelity National Info closed at $54.15.

JonesTrading initiated coverage on Cullinan Oncology Inc (NASDAQ:CGEM) with a Buy rating. The price target for Cullinan Oncology is set to $22.00. Cullinan Oncology earned $0.82 in the second quarter, compared to $3.77 in the year-ago quarter. The current stock performance of Cullinan Oncology shows a 52-week-high of $13.87 and a 52-week-low of $7.78. Moreover, at the end of the last trading period, the closing price was at $8.63.

With a Market Perform rating, TD Cowen initiated coverage on PayPal Holdings Inc (NASDAQ:PYPL). The price target seems to have been set at $66.00 for PayPal Holdings. For the second quarter, PayPal Holdings had an EPS of $1.16, compared to year-ago quarter EPS of $0.93. The stock has a 52-week-high of $95.57 and a 52-week-low of $56.53. At the end of the last trading period, PayPal Holdings closed at $57.48.

Oppenheimer initiated coverage on Immunogen Inc (NASDAQ:IMGN) with a Perform rating. The price target for Immunogen is set to $16.00. Immunogen earned $0.02 in the second quarter, compared to $0.24 in the year-ago quarter. The current stock performance of Immunogen shows a 52-week-high of $20.69 and a 52-week-low of $3.60. Moreover, at the end of the last trading period, the closing price was at $15.66.

Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ:STRO) with an Outperform rating. The price target for Sutro Biopharma is set to $10.00. In the second quarter, Sutro Biopharma showed an EPS of $0.64, compared to $0.55 from the year-ago quarter. The stock has a 52-week-high of $8.72 and a 52-week-low of $3.03. At the end of the last trading period, Sutro Biopharma closed at $3.38.

Bernstein initiated coverage on The Walt Disney Co (NYSE:DIS) with an Outperform rating. The price target for Walt Disney is set to $103.00. In the third quarter, Walt Disney showed an EPS of $1.03, compared to $1.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $118.18 and a 52-week-low of $78.73. Walt Disney closed at $80.81 at the end of the last trading period.

TD Cowen initiated coverage on Global Payments Inc (NYSE:GPN) with an Outperform rating. The price target for Global Payments is set to $150.00. Global Payments earned $2.62 in the second quarter, compared to $2.36 in the year-ago quarter. The stock has a 52-week-high of $129.69 and a 52-week-low of $92.28. At the end of the last trading period, Global Payments closed at $114.12.